Cabaletta Bio (CABA) Change in Account Payables (2018 - 2025)
Cabaletta Bio (CABA) recorded quarterly Change in Account Payables of -$1.7 million in Q4 2025, down 259.44% quarter-over-quarter from $1.1 million in Q3 2025, and down 163.12% on a YoY basis from $2.7 million in Q4 2024.
Cabaletta Bio (CABA) Change in Account Payables (2018 - 2025) Analysis & Trends
Cabaletta Bio's Change in Account Payables history runs 8 years deep, the most recent figure standing at -$1.7 million for Q4 2025.
- In Q4 2025, Change in Account Payables fell 163.12% year-over-year to -$1.7 million; the TTM figure through Dec 2025 stood at $1.5 million (up 53.31% YoY), while the FY2025 annual figure was $1.5 million, up 53.31% from the prior year.
- Change in Account Payables was -$1.7 million for Q4 2025 at Cabaletta Bio, down from $1.1 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.7 million in Q4 2024 to a low of -$2.0 million in Q3 2024.
- Historically, Change in Account Payables has averaged $259150.0 across 5 years, with a median of $580500.0 in 2021.
- Biggest YoY gain for Change in Account Payables was 620.36% in 2022; the steepest drop was 304.07% in 2022.
- A 5-year view of Change in Account Payables shows it stood at $566000.0 in 2021, then soared by 81.45% to $1.0 million in 2022, then plunged by 49.56% to $518000.0 in 2023, then jumped by 421.81% to $2.7 million in 2024, then tumbled by 163.12% to -$1.7 million in 2025.
- The last three Change in Account Payables figures came in at -$1.7 million (Q4 2025), $1.1 million (Q3 2025), and $595000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Cabaletta Bio | 151.84 Mn | 18.24 Mn | - | -1.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.71 Mn |
| Dec 31, 2025 | -1.71 Mn |
| Sep 30, 2025 | 1.07 Mn |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 595,000.00 |
| Jun 30, 2025 | 595,000.00 |
| Mar 31, 2025 | 1.59 Mn |
| Mar 31, 2025 | 1.59 Mn |
| Dec 31, 2024 | 2.70 Mn |
| Dec 31, 2024 | 2.70 Mn |
| Sep 30, 2024 | -2.01 Mn |
| Sep 30, 2024 | -2.01 Mn |
| Jun 30, 2024 | -1.34 Mn |
| Jun 30, 2024 | -1.34 Mn |
| Mar 31, 2024 | 1.66 Mn |
| Mar 31, 2024 | 1.66 Mn |
| Dec 31, 2023 | 518,000.00 |
| Dec 31, 2023 | 518,000.00 |
| Sep 30, 2023 | 1.30 Mn |
| Sep 30, 2023 | 1.30 Mn |